MCL-1 inhibition in cancer treatment

References

• Shamas-DinAKaleJLeberBAndrewsDWMechanisms of action of Bcl-2 family proteinsCold Spring Harb Perspect Biol201354a00871423545417
   PubMed Web of Science ®Google Scholar
• KrajewskiSBodrugSKrajewskaMImmunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivoAm J Pathol19951466130913197778670
   PubMed Web of Science ®Google Scholar
• PerciavalleRMOpfermanJTDelving deeper: MCL-1’s contributions to normal and cancer biologyTrends Cell Biol2013231222923026029
   PubMed Web of Science ®Google Scholar
• PeperzakVVikströmIWalkerJMcl-1 is essential for the survival of plasma cellsNat Immunol201314329029723377201
   PubMed Web of Science ®Google Scholar
• AdamsJMCorySThe Bcl-2 protein family: arbiters of cell survivalScience19982815381132213269735050
   PubMed Web of Science ®Google Scholar
• LabelleJLKatzSGBirdGHA stapled BIM peptide overcomes apoptotic resistance in hematologic cancersJ Clin Invest201212262018203122622039
   PubMed Web of Science ®Google Scholar
• CampbellKJDhayadeSFerrariNMCL-1 is a prognostic indicator and drug target in breast cancerCell Death Dis2018921929339815
   PubMed Web of Science ®Google Scholar
• YoungAILawAMCastilloLMCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinibBreast Cancer Res201618112527931239
   PubMed Web of Science ®Google Scholar
• ZervantonakisIKIavaroneCChenHYSystems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug responseNat Commun20178136528848242
   PubMed Web of Science ®Google Scholar
• ReinerTde Las PozasAParrondoRMcl-1 protects prostate cancer cells from cell death mediated by chemotherapy-induced DNA damageOncoscience20152870371526425662
   PubMedGoogle Scholar
• AkgulCMcl-1 is a potential therapeutic target in multiple types of cancerCell Mol Life Sci20096681326133619099185
   PubMed Web of Science ®Google Scholar
• BeroukhimRMermelCHPorterDThe landscape of somatic copy-number alteration across human cancersNature2010463728389990520164920
   PubMed Web of Science ®Google Scholar
• BalkoJMGiltnaneJMWangKMolecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targetsCancer Discov20144223224524356096
   PubMed Web of Science ®Google Scholar
• BeroukhimRMermelCHPorterDThe landscape of somatic copy-number alteration across human cancersNature2010463728389990520164920
   PubMed Web of Science ®Google Scholar
• DingQHeXXiaWMyeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancerCancer Res200767104564457117495324
   PubMed Web of Science ®Google Scholar
• XuCLiuYHuangJThe prognostic significance of MCL1 copy number gain in esophageal squamous cell carcinomaOncotarget2017850876998770929152113
   PubMedGoogle Scholar
• ThomasLWLamCEdwardsSWMcl-1; the molecular regulation of protein functionFEBS Lett2010584142981298920540941
   PubMed Web of Science ®Google Scholar
• WertzIEKusamSLamCSensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7Nature2011471733611011421368834
   PubMed Web of Science ®Google Scholar
• WeiSHDongKLinFInducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cellCancer Chemother Pharmacol20086261055106418297287
   PubMed Web of Science ®Google Scholar
• LestiniBJGoldsmithKCFluchelMNMcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonistsCancer Biol Ther20098161587159519556859
   PubMed Web of Science ®Google Scholar
• OsakiSTazawaHHaseiJAblation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomasSci Rep201662895327356624
   PubMed Web of Science ®Google Scholar
• GlabJADoerflingerMPuthalakathHBH3-only proteins: the thorny end of the ER stress responseCell Death Dis201786e288928640250
   PubMed Web of Science ®Google Scholar
• Shamas-DinABrahmbhattHLeberBBH3-only proteins: Orchestra-tors of apoptosisBiochimica et Biophysica Acta (BBA) – Molecular Cell Research2011181350852021146563
   PubMed Web of Science ®Google Scholar
• HaneefJParvathyMThankayyanRSKSithulHSreeharshanSBax translocation mediated mitochondrial apoptosis and caspase dependent photosensitizing effect of Ficus religiosa on cancer cellsPLoS One201277e4005522792212
   PubMed Web of Science ®Google Scholar
• D’AlessioMde NicolaMCoppolaSOxidative Bax dimerization promotes its translocation to mitochondria independently of apoptosisFaseb J200519111504150615972297
   PubMed Web of Science ®Google Scholar
• McarthurKWhiteheadLWHeddlestonJMBAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosisScience20183596378eaao604729472455
   PubMed Web of Science ®Google Scholar
• ZhangYQuYGaoKHigh copy number of mitochondrial DNA (mtDNA) predicts good prognosis in glioma patientsAm J Cancer Res2015531207121626045999
   PubMed Web of Science ®Google Scholar
• WeiXDuanWLiYAT101 exerts a synergetic efficacy in gastric cancer patients with 5-FU based treatment through promoting apoptosis and autophagyOncotarget2016723344303444127144437
   PubMedGoogle Scholar
• SenftDWeberASaathoffFIn non-transformed cells Bak activates upon loss of anti-apoptotic Bcl-XL and Mcl-1 but in the absence of active BH3-only proteinsCell Death Disease2015611e199626610208
   PubMed Web of Science ®Google Scholar
• García SáezAJVillungerAMOMP in the absence of BH3-only proteinsGenes Dev201630887888027083995
   PubMed Web of Science ®Google Scholar
• ElkholiRFlorosKVChipukJEThe Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and TreatmentGenes Cancer20112552353721901166
   PubMedGoogle Scholar
• KodamaTTakeharaTHikitaHBH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in plateletsJ Biol Chem201128616139051391321367852
   PubMed Web of Science ®Google Scholar
• VelaLGonzaloONavalJMarzoIDirect interaction of Bax and Bak proteins with Bcl-2 homology domain 3 (BH3)-only proteins in living cells revealed by fluorescence complementationJ Biol Chem201328874935494623283967
   PubMed Web of Science ®Google Scholar
• ZhaiDJinCHuangZSatterthwaitACReedJCDifferential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1J Biol Chem2008283159580958618178565
   PubMed Web of Science ®Google Scholar
• MonteroJLetaiAWhy do BCL-2 inhibitors work and where should we use them in the clinic?Cell Death Differ2018251566429077093
   PubMed Web of Science ®Google Scholar
• HaschkaMDSoratroiCKirschnekSThe NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrestNat Commun20156689125922916
   PubMed Web of Science ®Google Scholar
• HappoLStrasserACorySBH3-only proteins in apoptosis at a glanceJ Cell Sci2012125Pt 51081108722492984
   PubMed Web of Science ®Google Scholar
• ChenLFletcherSMcl-1 inhibitors: a patent reviewExpert Opin Ther Pat20172716317827744724
   PubMed Web of Science ®Google Scholar
• NhuDLesseneGHuangDCSBurnsCJSmall molecules targeting Mcl-1: the search for a silver bullet in cancer therapyMedchemcomm201675778787
   Web of Science ®Google Scholar
• WangGNikolovska-ColeskaZYangCYStructure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteinsJ Med Chem200649216139614217034116
   PubMed Web of Science ®Google Scholar
• RenTShanJQingYSequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathwayDrug Des Devel Ther2014825172529
   Web of Science ®Google Scholar
• KotschyASzlavikZMurrayJThe MCL1 inhibitor S63845 is tolerable and effective in diverse cancer modelsNature2016538762647748227760111
   PubMed Web of Science ®Google Scholar
• CastroJELoriaOJAguillonRAA Phase II, Open Label Study of AT-101 in Combination with Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia. Evaluation of Two Dose RegimensBlood20071103119
   Web of Science ®Google Scholar
• MohammadRMGoustinASAboukameelAPreclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1Clin Cancer Res20071372226223517404107
   PubMed Web of Science ®Google Scholar
• AshimoriNZeitlinBDZhangZTW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesisMol Cancer Ther20098489390319372562
   PubMed Web of Science ®Google Scholar
• ZhaiDJinCShiauCWKitadaSSatterthwaitACReedJCGam-bogic acid is an antagonist of antiapoptotic Bcl-2 family proteinsMol Cancer Ther2008761639164618566235
   PubMed Web of Science ®Google Scholar
• LiXLiuSHuangHGambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivoCell Rep20133121122223260670
   PubMed Web of Science ®Google Scholar
• HuaXLiangCDongLQuXZhaoTSimultaneous determination and pharmacokinetic study of gambogic acid and gambogenic acid in rat plasma after oral administration of Garcinia hanburyi extracts by LC-MS/MSBiomed Chromatogr201529454555125159917
   PubMed Web of Science ®Google Scholar
• DashRAzabBQuinnBAApogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicityProc Natl Acad Sci U S A2011108218785879021555592
   PubMed Web of Science ®Google Scholar
• JacksonRSPlaczekWFernandezASabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancerNeoplasia201214765666522904682
   PubMed Web of Science ®Google Scholar
• WeiJStebbinsJLKitadaSBI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteinsJ Med Chem201053104166417620443627
   PubMed Web of Science ®Google Scholar
• DoiKLiRSungSSDiscovery of marinopyrrole A (maritoclax) as a selective Mcl-1 antagonist that overcomes ABT-737 resistance by binding to and targeting Mcl-1 for proteasomal degradationJ Biol Chem201228713102241023522311987
   PubMed Web of Science ®Google Scholar
• AbulwerdiFLiaoCLiuMA novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivoMol Cancer Ther201413356557524019208
   PubMed Web of Science ®Google Scholar
• OhmerMWeberASutterGEhrhardtKZimmermannAHäckerGAnti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosisCell Death Dis201678e234027537523
   PubMed Web of Science ®Google Scholar
• ZhaoBSensintaffarJBianZStructure of a Myeloid cell leukemia-1 (Mcl-1) inhibitor bound to drug site 3 of Human Serum AlbuminBioorg Med Chem201725123087309228428041
   PubMed Web of Science ®Google Scholar
• FribergAVigilDZhaoBDiscovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based DesignJournal of Medicinal Chemistry201356153023244564
   PubMed Web of Science ®Google Scholar
• HirdAWSecristJPAdamAAbstract DDT0102: AZD5991: A potent and selective macrocyclic inhibitor of Mcl-1 for treatment of hematologic cancersCancer Research2017;7713DDT0102
   Google Scholar
• DoiKGowdaKLiuQPyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cellsCancer Biol Ther201415121688169925535900
   PubMed Web of Science ®Google Scholar
• LeversonJDZhangHChenJPotent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)Cell Death Dis20156e159025590800
   PubMed Web of Science ®Google Scholar
• XiaoYNimmerPSheppardGSMCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule InhibitorMol Cancer Ther20151481837184726013319
   PubMed Web of Science ®Google Scholar
• LinJFuDDaiYLinJXuTMcl-1 inhibitor suppresses tumor growth of esophageal squamous cell carcinoma in a mouse modelOncotarget201787011445711446229383093
   PubMedGoogle Scholar
• PelzNFBianZZhaoBDiscovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based MethodsJ Med Chem20165952054206626878343
   PubMed Web of Science ®Google Scholar
• MerinoDWhittleJRVaillantFSynergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancerSci Transl Med20179401eaam704928768804
   PubMed Web of Science ®Google Scholar
• CaenepeelSRBelmontesBSunJCoxonAMoodyGHughesPEAbstract 2027: Preclinical evaluation of AMG 176, a novel, potent and selective Mcl-1 inhibitor with robust anti-tumor activity in Mcl-1 dependent cancer modelsCancer Research201777132027
   Web of Science ®Google Scholar
• NijhawanDFangMTraerEElimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiationGenes Dev200317121475148612783855
   PubMed Web of Science ®Google Scholar
• JourdanMVeyruneJLde VosJRedalNCoudercGKleinBA major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cellsOncogene200322192950295912771946
   PubMed Web of Science ®Google Scholar
• DashRRichardsJESuZZMechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokineCancer Res201070125034504520501829
   PubMed Web of Science ®Google Scholar
• ShenoyARKirschnekSHäckerGIL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and PI3K/AKT pathways in T cellsEur J Immunol20144482500250724825007
   PubMed Web of Science ®Google Scholar
• FuNYRiosACPalBEGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survivalNat Cell Biol201517436525730472
   PubMed Web of Science ®Google Scholar
• VéronèseLTournilhacOVerrellePStrong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lympho-cytic leukemiaLeuk Res200933121623162619487028
   PubMed Web of Science ®Google Scholar
• IqbalSZhangSDrissAPDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cellsPLoS One201271e3076422276222
   PubMed Web of Science ®Google Scholar
• WakatsukiSTokunagaSShibataMArakiTGSK3B-mediated phosphorylation of MCL1 regulates axonal autophagy to promote Wallerian degenerationJ Cell Biol2017216247749328053206
   PubMed Web of Science ®Google Scholar
• BettayebKBaunbækDDelehouzeCCDK Inhibitors Rosco-vitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma CellsGenes Cancer20101436938021779453
   PubMedGoogle Scholar
• DelehouzéCGodlKLoaëcNCDK/CK1 inhibitors roscovi-tine and CR8 downregulate amplified MYCN in neuroblastoma cellsOncogene201433505675568724317512
   PubMed Web of Science ®Google Scholar
• CerellaCMullerFGaigneauxAEarly downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450Cell Death Dis201566e178226068790
   PubMed Web of Science ®Google Scholar
• RahmaniMDavisEMBauerCDentPGrantSApoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translationJ Biol Chem200528042352173522716109713
   PubMed Web of Science ®Google Scholar
• LeeJSTangSSOrtizVVoTTFrumanDAMCL-1-independent mechanisms of synergy between dual PI3K/mTOR and BCL-2 inhibition in diffuse large B cell lymphomaOncotarget2015634352023521726460954
   PubMedGoogle Scholar
• WangRXiaLGabriloveJWaxmanSJingYDownregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cellsLeukemia201327231532422751450
   PubMed Web of Science ®Google Scholar
• KangXHZhangJHZhangQQDegradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 CellsCell Physiol Biochem20174152067207628419994
   PubMed Web of Science ®Google Scholar
• PangYPDaiHSmithAMengXWSchneiderPAKaufmannSHBak Conformational Changes Induced by Ligand Binding: Insight into BH3 Domain Binding and Bak Homo-OligomerizationSci Rep2012225722355769
   PubMed Web of Science ®Google Scholar
• IyerSAnwariKAlsopAEIdentification of an activation site in Bak and mitochondrial Bax triggered by antibodiesNat Commun201671173427217060
   PubMed Web of Science ®Google Scholar
• LiMXTanIKLMaSBBAK α6 permits activation by BH3-only proteins and homooligomerization via the canonical hydrophobic grooveProc Natl Acad Sci U S A2017114297629763428673969
   PubMed Web of Science ®Google Scholar
• XinMLiRXieMSmall-molecule Bax agonists for cancer therapyNat Commun20145493525230299
   PubMed Web of Science ®Google Scholar
• BrinkmannKGrabowSHylandCDThe combination of reduced MCL-1 and standard chemotherapeutics is tolerable in miceCell Death Differ201724122032204328800129
   PubMed Web of Science ®Google Scholar
• LuedtkeDANiuXPanYInhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cellsSignal Transduct Target Ther201721701229263915
   PubMed Web of Science ®Google Scholar
• LianBSXYekAEHShuvasHAbdul RahmanSFMuniandyKMohana-KumaranNSynergistic anti-proliferative effects of combination of ABT-263 and MCL-1 selective inhibitor A-1210477 on cervical cancer cell linesBMC Res Notes201811119729580266
   PubMedGoogle Scholar
• WeiDZhangQSchreiberJSTargeting mcl-1 for radiosensitization of pancreatic cancersTransl Oncol201581475425749177
   PubMed Web of Science ®Google Scholar
• Martinez MolinaDJafariRIgnatushchenkoMMonitoring drug target engagement in cells and tissues using the cellular thermal shift assayScience2013341848723828940
   PubMed Web of Science ®Google Scholar
• BaiLChenJMceachernDBM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivoPLoS One20149e9940424901320
   PubMed Web of Science ®Google Scholar
• ZhangHGuttikondaSRobertsLMcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell linesOncogene2011301963196821132008
   PubMed Web of Science ®Google Scholar
• WeiGMargolinAAHaeryLChemical genomics identifies small-molecule MCL1 repressors and BCL-xL as a predictor of MCL1 dependencyCancer Cell20122154756222516262
   PubMed Web of Science ®Google Scholar
• KotschyASzlavikZMurrayJThe MCL1 inhibitor S63845 is tolerable and effective in diverse cancer modelsNature201653847727760111
   PubMed Web of Science ®Google Scholar
• NeklesaTKWinklerJDCrewsCMTargeted protein degradation by PROTACsPharmacol Ther201717413814428223226
   PubMed Web of Science ®Google Scholar
• DeyJDeckwerthTLKerwinWSVoruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibitionSci Rep201771800729269870
   PubMed Web of Science ®Google Scholar